Report cover image

Infection Surveillance Solution Market by Product (Services, Software), Deployment (On-Cloud, On-Premise), End-User - Global Forecast 2024-2030

Publisher 360iResearch
Published Jan 15, 2024
Length 186 Pages
SKU # IRE18444980

Description

Infection Surveillance Solution Market by Product (Services, Software), Deployment (On-Cloud, On-Premise), End-User - Global Forecast 2024-2030


The Infection Surveillance Solution Market size was estimated at USD 768.47 million in 2023 and expected to reach USD 867.99 million in 2024, at a CAGR 13.36% to reach USD 1,849.73 million by 2030.

Global Infection Surveillance Solution Market Infection surveillance solutions predict resident and healthcare staff infections in real-time and control possible epidemics. The solutions record infection data and turn it into actionable insights for strategic planning to prevent potential infections. The instances of hospital-acquired infections in adults grow the market. However, there is a need to employ cost-effective measures to adopt infection surveillance tools by small-scale laboratories and healthcare facilities. The ongoing innovations based on artificial intelligence and data analytics are improving the efficiency of infection surveillance solutions by combining them with electronic medical records.Regional InsightsIn the Americas, Government agencies such as the Centers for Disease Control and Prevention (CDC) manages infection surveillance through secure, internet-based surveillance systems of national healthcare safety networks. The increasing number of patients suffering from infectious diseases and the need for antimicrobial tracking surged the need for infection surveillance solutions in the market. The market players in the Americas are advancing innovative technologies for infection surveillance based on artificial intelligence and data science tools. Public and private sector is investing in research and development of innovative technologies in infection surveillance in the region.The Middle East and Africa's market is anticipated to boost due to growing healthcare sector in the region. The Asia-Pacific region is expected to raise the market demand due to the increasing number of healthcare facilities. The growing awareness about antimicrobial resistance and hospital-acquired infections is the rising adoption of infection surveillance solutions in the region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Infection Surveillance Solution Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Infection Surveillance Solution Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Infection Surveillance Solution Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Altarum, Baxter International, Inc., Becton, Dickinson and Company, bioMérieux SA, BioVigil Healthcare Systems, Inc., Cardinal Health Inc., CenTrak, Inc., Clinsys, Inc., Conduent, Inc., Datlowe, s.r.o., DNV AS, Ecolab Inc., Gunnebo Entrance Control Ltd., Health Matrix., Ibhar Technologies Pvt Ltd, Inovalon, International Business Machines Corporation, Medexter Healthcare GmbH, Oracle Corporation, PointClickCare, Premier Inc., RLDatix, Securitas Healthcare, LLC., Strategic Solutions Group, Thermo Fisher Scientific Inc., Vecna Technologies, Inc., VigiLanz Corporation, Vitalacy Inc., Vizzia Technologies, and Wolters Kluwer N.V..

Market Segmentation & Coverage

This research report categorizes the Infection Surveillance Solution Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
Services
Implementation Services

Product Support & Maintainnace Services

Training & Consulting Services

Software
Antimicrobial Monitoring & Control

Infection Surveillance
Laboratory surveillance

Surgical surveillance & patient monitoring

Outbreak Management
Isolation Management

Potential Outbreak Alert

Staff Health & Compliance

Deployment
On-Cloud

On-Premise

End-User
Hospital

Laboratories

Long-Term Care Facility

Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas

Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam

Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Infection Surveillance Solution Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Infection Surveillance Solution Market?
3. What are the technology trends and regulatory frameworks in the Infection Surveillance Solution Market?
4. What is the market share of the leading vendors in the Infection Surveillance Solution Market?
5. Which modes and strategic moves are suitable for entering the Infection Surveillance Solution Market?

Note: PDF & Excel + Online Access - 1 Year

Table of Contents

186 Pages
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Infection Surveillance Solution Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing geriatric population coupled with increasing incidences of chronic diseases
5.1.1.2. Increasing prevalence of hospital-acquired infections (HAIs)
5.1.1.3. Rising adoption of antimicrobial stewardship programs
5.1.2. Restraints
5.1.2.1. High cost associated with the deployment of infection surveillance solutions
5.1.3. Opportunities
5.1.3.1. Development of fully automated infection surveillance solution systems with the integration of electronic medical records
5.1.3.2. Rapid emergence of cloud based infection surveillance solutions
5.1.4. Challenges
5.1.4.1. Limited availability of skilled healthcare IT professional
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Infection Surveillance Solution Market, by Product
6.1. Introduction
6.2. Services
6.3.1. Implementation Services
6.3.2. Product Support & Maintainnace Services
6.3.3. Training & Consulting Services
6.3. Software
6.4.1. Antimicrobial Monitoring & Control
6.4.2. Infection Surveillance
6.4.3.1. Laboratory surveillance
6.4.3.2. Surgical surveillance & patient monitoring
6.4.3. Outbreak Management
6.4.4.1. Isolation Management
6.4.4.2. Potential Outbreak Alert
6.4.4. Staff Health & Compliance
7. Infection Surveillance Solution Market, by Deployment
7.1. Introduction
7.2. On-Cloud
7.3. On-Premise
8. Infection Surveillance Solution Market, by End-User
8.1. Introduction
8.2. Hospital
8.3. Laboratories
8.4. Long-Term Care Facility
9. Americas Infection Surveillance Solution Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Infection Surveillance Solution Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.
10. South Korea
10.
11. Taiwan
10.
12. Thailand
10.
13. Vietnam
11. Europe, Middle East & Africa Infection Surveillance Solution Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.
10. Nigeria
11.
11. Norway
11.
12. Poland
11.
13. Qatar
11.
14. Russia
11.
15. Saudi Arabia
11.
16. South Africa
11.
17. Spain
11.
18. Sweden
11.
19. Switzerland
11.
20. Turkey
11.
21. United Arab Emirates
11.
22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
12.3.1. Merger & Acquisition
12.3.1.1. Orbis Protect Acquires Secure Site UK to Further Enhance Their Security Solutions & Service Offering.
12.3.2. Agreement, Collaboration, & Partnership
12.3.2.1. Bitscopic’s Clinical Surveillance Software to be Implemented at VA Los Angeles and VA Las Vegas.
12.3.3. New Product Launch & Enhancement
12.3.3.1. RACGP Launches New Infection Prevention and Control Guidelines.
12.3.3.2. MIT Chemists Develop a Wireless Electronic Lateral Flow Assay Test for Biosensing.
12.3.3.3. Infection Prevention and Control Online Learning Launched.
12.3.3.4. Premier Brings PINC AI Clinical Surveillance Technology to Long-Term Care Facilities.
12.3.4. Investment & Funding
12.3.4.1. American Firm Named as Sole Supplier For £20m (USD 24.06 Million) Framework.
12.3.4.2. Foresight Group Invests Additional £1 Million (USD 1.20 Million) from the Midlands Engine Investment Fund into ReadyGo Diagnostics Limited.
12.3.5. Award, Recognition, & Expansion
12.3.5.1. West Hartford-Bloomfield Health District Coalition Against Healthcare-Acquired Infections Team Recognized as NACCHO Infection Prevention and Control Champion.
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. 3M Company
13.1.2. Altarum
13.1.3. Baxter International, Inc.
13.1.4. Becton, Dickinson and Company
13.1.5. bioMérieux SA
13.1.6. BioVigil Healthcare Systems, Inc.
13.1.7. Cardinal Health Inc.
13.1.8. CenTrak, Inc.
13.1.9. Clinsys, Inc.
13.1.
10. Conduent, Inc.
13.1.
11. Datlowe, s.r.o.
13.1.
12. DNV AS
13.1.
13. Ecolab Inc.
13.1.
14. Gunnebo Entrance Control Ltd.
13.1.
15. Health Matrix.
13.1.
16. Ibhar Technologies Pvt Ltd
13.1.
17. Inovalon
13.1.
18. International Business Machines Corporation
13.1.
19. Medexter Healthcare GmbH
13.1.
20. Oracle Corporation
13.1.
21. PointClickCare
13.1.
22. Premier Inc.
13.1.
23. RLDatix
13.1.
24. Securitas Healthcare, LLC.
13.1.
25. Strategic Solutions Group
13.1.
26. Thermo Fisher Scientific Inc.
13.1.
27. Vecna Technologies, Inc.
13.1.
28. VigiLanz Corporation
13.1.
29. Vitalacy Inc.
13.1.
30. Vizzia Technologies
13.1.
31. Wolters Kluwer N.V.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
FIGURE 1. INFECTION SURVEILLANCE SOLUTION MARKET RESEARCH PROCESS
FIGURE 2. INFECTION SURVEILLANCE SOLUTION MARKET SIZE, 2023 VS 2030
FIGURE 3. INFECTION SURVEILLANCE SOLUTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. INFECTION SURVEILLANCE SOLUTION MARKET DYNAMICS
FIGURE 7. INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2023 VS 2030 (%)
FIGURE 10. INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. INFECTION SURVEILLANCE SOLUTION MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. INFECTION SURVEILLANCE SOLUTION MARKET SHARE, BY KEY PLAYER, 2023

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us